REGN vs. SNY
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or SNY.
Correlation
The correlation between REGN and SNY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. SNY - Performance Comparison
Key characteristics
REGN:
-0.75
SNY:
-0.07
REGN:
-0.90
SNY:
0.06
REGN:
0.88
SNY:
1.01
REGN:
-0.40
SNY:
-0.07
REGN:
-1.09
SNY:
-0.18
REGN:
15.08%
SNY:
8.86%
REGN:
21.92%
SNY:
22.20%
REGN:
-91.81%
SNY:
-46.65%
REGN:
-41.50%
SNY:
-18.91%
Fundamentals
REGN:
$81.32B
SNY:
$122.70B
REGN:
$40.40
SNY:
$1.89
REGN:
18.32
SNY:
25.89
REGN:
1.10
SNY:
0.76
REGN:
$13.85B
SNY:
$59.54B
REGN:
$11.69B
SNY:
$40.42B
REGN:
$4.83B
SNY:
$11.26B
Returns By Period
In the year-to-date period, REGN achieves a -19.96% return, which is significantly lower than SNY's -4.56% return. Over the past 10 years, REGN has outperformed SNY with an annualized return of 5.47%, while SNY has yielded a comparatively lower 3.87% annualized return.
REGN
-19.96%
-5.59%
-32.69%
-16.49%
13.38%
5.47%
SNY
-4.56%
-1.13%
1.30%
-1.56%
1.77%
3.87%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. SNY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. SNY - Dividend Comparison
REGN has not paid dividends to shareholders, while SNY's dividend yield for the trailing twelve months is around 4.29%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SNY Sanofi | 4.29% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% | 3.47% |
Drawdowns
REGN vs. SNY - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than SNY's maximum drawdown of -46.65%. Use the drawdown chart below to compare losses from any high point for REGN and SNY. For additional features, visit the drawdowns tool.
Volatility
REGN vs. SNY - Volatility Comparison
The current volatility for Regeneron Pharmaceuticals, Inc. (REGN) is 7.59%, while Sanofi (SNY) has a volatility of 8.69%. This indicates that REGN experiences smaller price fluctuations and is considered to be less risky than SNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
REGN vs. SNY - Financials Comparison
This section allows you to compare key financial metrics between Regeneron Pharmaceuticals, Inc. and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities